These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8902767)

  • 1. Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies.
    Galli M
    Lupus; 1996 Oct; 5(5):388-92. PubMed ID: 8902767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Laboratory tests for detection of antiphospholipid antibodies].
    Yasumuro Y; Taki M
    Rinsho Byori; 2001 Mar; Suppl 115():91-102. PubMed ID: 11391941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
    Barbui T; Finazzi G; Galli M
    Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies: specificity and pathophysiology.
    de Groot PG; Oosting JD; Derksen RH
    Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New targets of antiphospholipid antibodies].
    Arvieux J; Darnige L; Sarrot-Reynauld F
    Rev Med Interne; 1997; 18(4):292-302. PubMed ID: 9161556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin.
    Bevers EM; Zwaal RF; Willems GM
    Clin Immunol; 2004 Aug; 112(2):150-60. PubMed ID: 15240158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic role of antiprotein-phospholipid antibodies.
    Carreras LO; Forastiero RR
    Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
    Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
    Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?
    Galli M
    J Autoimmun; 2000 Sep; 15(2):101-5. PubMed ID: 10968893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of the antiphospholipid antibody syndrome: an update.
    Singh AK
    Curr Opin Nephrol Hypertens; 2001 May; 10(3):355-8. PubMed ID: 11342797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'.
    Kandiah DA; Sheng YH; Krilis SA
    Lupus; 1996 Oct; 5(5):381-5. PubMed ID: 8902765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies: proposed mechanisms of action.
    Triplett DA
    Am J Reprod Immunol; 1992; 28(3-4):211-5. PubMed ID: 1285881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lupus anticoagulants versus antiphospholipid antibodies].
    Pereira MI
    Acta Med Port; 1998 Apr; 11(4):349-57. PubMed ID: 9644846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.